Litigation Details for SILBERSHER v. JANSSEN BIOTECH INC. (D.N.J. 2019)
✉ Email this page to a colleague
SILBERSHER v. JANSSEN BIOTECH INC. (D.N.J. 2019)
Docket | ⤷ Sign Up | Date Filed | 2019-05-03 |
Court | District Court, D. New Jersey | Date Terminated | |
Cause | 31:3729 False Claims Act | Assigned To | Michael E. Farbiarz |
Jury Demand | Both | Referred To | Stacey D. Adams |
Patents | 7,125,879; 7,157,456; 7,585,860; 7,592,339; 8,022,082; 8,080,551; 8,101,629; 8,163,798; 8,518,987; 8,822,438; 8,841,310; 9,144,549 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in SILBERSHER v. JANSSEN BIOTECH INC.
Details for SILBERSHER v. JANSSEN BIOTECH INC. (D.N.J. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2017-12-20 | 1 | Complaint | fraudulently obtained patent is U.S. Patent 8,822,438 (the '438 11 Patent). 12 5. …compound patent covering Zytiga- U.S. Patent No. 5,604,213 (the 4 "'213 Patent")-expired…the '438 Patent 2 60. The Patent Office allowed the '438 Patent because of false… the patent's examination. The Patent Office originally rejected the '438 4 Patent application…Under applicable patent law, an application for a patent will be rejected by the Patent 14 Office if | External link to document |
2021-04-06 | 128 | Request for Judicial Notice | U.S. Patent No. 5,604,213 (issued Feb. 18, 1997). Exhibit B – U.S. Patent No. 8,822,438 (issued… from Certified File Wrapper of U.S. Patent No. 8,822,438, Patent Application No. 13/034,340 (filed… during the ’438 patent prosecution and are available via the PTO’s Public Patent Application Information… Documents, submitted June 4, 2013, for U.S. Patent Application No. 13/034,430 (filed Feb. 24, 2011…Specification, submitted Feb. 24, 2011, for U.S. Patent Application No. 13/034,430 (filed Feb. 24, 2011 | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |